Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Riluzole may stop or slow the growth of tumor cells and may be an effective
treatment for melanoma.
PURPOSE: This phase II trial is studying how well riluzole works in treating patients with
stage III or stage IV melanoma that cannot be removed by surgery.